Mushroom compounds in controlling the development of Alzheimer’s

( organic whole foods that positively impact or help prevent diseases )

PleaseHelpSupport Alzheimer's Research Today!
Your Alzheimer's donation will help billionslive without it. Donate online now

Total Nutraceutical Solutions, Inc. (TNS) (OTCBB:TNUS), announced today that the company has started evaluating several proprietary mushroom compounds for activity in controlling the development of Alzheimer’s Disease (AD). TNS was informed by Model Biosystems, Inc. (MBS), San Clemente, CA, that a recent experiment in Drosophila melanogaster flies (Drosophila) showed that certain TNS proprietary mushrooms had unusual anti-inflammatory activity. MBS was of the opinion that TNS should evaluate these mushroom samples in a special MBS biologic model for Alzheimer’s disease (AD). This proprietary AD model uses a genetic mutant of Drosophila that was developed in the laboratory of Dr. Krishna Bhat, University of Texas, Galveston, Texas. This unique live model system can evaluate the activity of a given compound/ingredient in controlling biologic reactions and compounds that are associated with the development of human AD. The organic whole food mushrooms developed by TNS are being studied, pursuant to a signed research agreement, dated Friday, October 30, 2009, in a double-blinded investigator protocol; the total study will involve over 1,000 Drosophila with 120 organisms in each test group.
Drosophila melanogaster, or fruit-fly is widely used in scientific and medical research. Its importance for human health was recognized by the award of the Nobel Prize for medicine in 1995, for work on the genetic control of early embryonic development. Mutant flies with defects in any of several thousand genes are available, and the entire genome has recently been sequenced. Drosophila helped in the development of drugs to combat pathogens responsible for a range of diseases from skin infections to pneumonia and meningitis. Recent research with fruit-flies has focused on the pathology of Alzheimer’s disease, particularly because of the similarity between human and fly brains and the conservation of the AD genetic pathway.

“The discovery and development of organic whole foods that positively impact or help prevent diseases are welcome breakthroughs in healthcare, as more and more people demand natural alternatives to prevent disease,” stated Marvin S. Hausman MD, CEO, TNS. “We believe that the unique, proprietary technology developed by TNS and used in the production of our natural organic specialty mushrooms, contributes significantly to the potential success of this new Alzheimer’s disease study to be undertaken by TNS and MBS.”

“I am pleased that MBS is able to offer TNS the services of our biotechnology testing in their research and development of natural organic mushrooms for alternative medical approaches to preventing human diseases,” stated Malli Varanasi, President, MBS. “Alzheimer’s disease is a terrible human affliction and new preventative measures would be well-received by all people.” ...http://www.earthtimes.org

Paper proving source of antioxidants for Swiss firm

A Swiss company extracting what it claims are antioxidant polyphenols from pulp and paper processing waste is to scale up the project to offer the product as a functional food ingredient. ...http://www.nutraingredients.com

Беларусь ТВ

Posted YVN